Clinical Trials in Dallas

Showing 3861-3880 of 17,468 trials

Cancer Clinical Trials Financial Reimbursement Program

NCT05402033

To implement a Financial Reimbursement and Outreach Program at clinical sites within the Harold C. Simmons Comprehensive Cancer Center; and evaluate the impact of the program on clinical trial enrollment and demographics, as well as facilitators of and barriers to program participation.

Cancer Clinical Trials

University of Texas Southwestern Medical Center1,200 participantsStarted Jul 2022

Dallas, Texas, United States

RECRUITINGPhase 1/2< 1 mile

Promising ROd-cone DYstrophy Gene therapY

NCT05748873

This is a two-step, multicenter, Phase I/II study including an open-label dose-escalation phase (Step 1) and a three-arm, controlled, double-masked, randomized extension phase (Step 2), in subjects with advanced RCD due to a mutation in the RHO, PDE6A, or PDE6B gene.

Retinitis Pigmentosa

SparingVision33 participantsStarted Apr 2023

Miami, Florida, United States • Boston, Massachusetts, United States • Portland, Oregon, United States +3 more locations

COMPLETEDPhase 1< 1 mile

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants

NCT05906836

The main purpose of this study is to determine the effect of selpercatinib on the levels of rosuvastatin in the blood stream in healthy participants. This study also evaluated the safety and tolerability of rosuvastatin when administered in combination with selpercatinib in healthy participants. This study will last up to approximately 26 days excluding screening period.

Healthy

Eli Lilly and Company28 participantsStarted Jul 2023

Dallas, Texas, United States

Cancer Clinical Trials Financial Reimbursement Program

Promising ROd-cone DYstrophy Gene therapY

A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants

Find Trials by Condition in Dallas

Study of Anti-Malarials in Incomplete Lupus Erythematosus

Exploring Neurophysiological Markers of Brain Health

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

OPTI-FREE Family STUDY

NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Locking Plates for Distal Femur Fractures - a Multicenter Case Review

28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Omnipod 5 System Compared to Pump Therapy

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis

A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery

Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer